DRTS (Alpha Tau Medical) Pre-Tax Income: $-92.40 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DRTS Alpha Tau Medical Ltd DRTS
27 GF Score
Price $14.69
! 3 Warning Signs
View Full Analysis

What is Alpha Tau Medical Pre-Tax Income?

Alpha Tau Medical DRTS -1.35% 27 Pre-Tax Income is $-92.40 Mil as of Jun. 2026. GuruFocus rates DRTS with a GF Score™ of 27/100. The stock has 3 warning signs investors should review.

Pretax income is the income that a company earns before paying income taxes. Alpha Tau Medical's pretax income for the three months ended in Jun. 2026 was $-45.58 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2026 was $-92.40 Mil. Alpha Tau Medical's pretax margin was %.


Alpha Tau Medical  (NAS:DRTS) Pre-Tax Income Explanation

Alpha Tau Medical's Pretax Margin for the quarter that ended in Jun. 2026 is calculated as

Pretax Margin=Pretax Income/Revenue
=-45.584/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alpha Tau Medical Pre-Tax Income Related Terms


Alpha Tau Medical Pre-Tax Income Historical Data

* Premium members only.

The historical data trend for Alpha Tau Medical's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha Tau Medical Pre-Tax Income Chart

Alpha Tau Medical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Pre-Tax Income
Get a 7-Day Free Trial -27.26 -33.74 -29.14 -31.74 -42.51

Alpha Tau Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.05 -11.69 -12.17 -22.95 -45.58

DRTS vs SPTX, SVRA, CAPR: Pre-Tax Income Comparison

For the Biotechnology subindustry, Alpha Tau Medical's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha Tau Medical Pre-Tax Income vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Tau Medical's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Alpha Tau Medical's Pre-Tax Income falls into.


DRTS
27GF Score
Alpha Tau Medical Ltd DRTS
Pre-Tax Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Tau Medical Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Alpha Tau Medical's Pretax Income for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-42.288+-3.636+-0.347+3.837+-0.072000000000003
=-42.51

Alpha Tau Medical's Pretax Income for the quarter that ended in Jun. 2026 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-13.782+0+0+0+-31.802
=-45.58

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-92.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pre-Tax Income →
What does a Pre-Tax Income of $-92.40 Mil mean?
Alpha Tau Medical (DRTS) has a Pre-Tax Income of $-92.40 Mil as of Jun. 2026. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Alpha Tau Medical and its competitors.
Is Alpha Tau Medical's Pre-Tax Income too high?
Alpha Tau Medical's current Pre-Tax Income is $-92.40 Mil. Overall, Alpha Tau Medical has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Tau Medical's Pre-Tax Income compare to SPTX and SVRA?
Alpha Tau Medical's Pre-Tax Income of $-92.40 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Biotechnology company?
A good Pre-Tax Income depends on the Biotechnology industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Alpha Tau Medical and its competitors. Alpha Tau Medical's current Pre-Tax Income is $-92.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Tau Medical stock overvalued right now?
Alpha Tau Medical (DRTS) has a current Pre-Tax Income of $-92.40 Mil. The current Pre-Tax Income is $-92.40 Mil. Alpha Tau Medical's overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Alpha Tau Medical (DRTS), the current Pre-Tax Income is $-92.40 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha Tau Medical Business Description

Other Exchanges DRTS:Israel
Address Kiryat HaMada Street 5, Jerusalem, ISR, 9777605
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
27GF Score

Get the complete analysis for DRTS

Pre-Tax Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.69
Price